Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Embecta Corp. alleging that the company made materially false and misleading statements about its business and guidance during the period from November 25, 2025 to May 4, 2026. The complaint claims Embecta's pen needle business guidance was unattainable, as the company subsequently missed Q2 2026 expectations with a 14% revenue decline and cut full-year guidance, citing weakness in US pen needle sales.